King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Amr Hanbali
Dr. Amr Hanbali is a Consultant Haematologist in the Adult Oncology Division specialising in acute leukaemia, adolescent and young adult (AYA) leukaemia protocols, and rare plasma cell disorders — a dedicated acute leukaemia specialist in Riyadh, Saudi Arabia offering advanced haematology care to international patients. He is lead author of a major pediatric-inspired AYA T-ALL protocol study and a key contributor to the Gulf Cooperation Council (GCC) adult ALL consensus guidelines.
- Consultant Haematologist specialising in Acute Leukaemia and AYA leukaemia protocols
- Lead author of a pediatric-inspired AYA T-ALL protocol study
- Lead author on a 79-patient AYA acute lymphoblastic leukaemia outcomes study
- Contributing author to the GCC Adult ALL Consensus guidelines
- Corresponding author on hairy cell leukaemia–plasma cell leukaemia case report
Qualifications & Credentials
Medical Degrees
- MBBS — Bachelor of Medicine and Bachelor of Surgery
- Internal Medicine Residency
Fellowships & Special Training
- Fellowship in Adult Haematology
- Fellowship in Acute Leukaemia and Stem Cell Transplantation
- Advanced Training in Adolescent & Young Adult (AYA) Leukaemia Protocols
Certifications & Accreditations
- Saudi Commission for Health Specialties (SCFHS) — Registered Consultant
- American Society of Hematology (ASH) — Member
- European Hematology Association (EHA) — Member
Areas of Expertise
Major Conditions Treated
- Acute Lymphoblastic Leukaemia (B-ALL, T-ALL)
- Acute Myeloid Leukaemia (AML)
- AYA Acute Leukaemia (Adolescent and Young Adult)
- Chronic Myeloid Leukaemia (CML)
- Myelodysplastic Syndrome (MDS)
- Hairy Cell Leukaemia
- Plasma Cell Leukaemia
- Rare Haematological Malignancies
Sub-specialties
- AYA Acute Leukaemia Protocols: Pediatric-inspired treatment regimens for adolescents and young adults with ALL (including T-ALL) — a leading acute leukaemia specialist in Riyadh for AYA international patients.
- Acute Myeloid Leukaemia Management: Induction chemotherapy, venetoclax-based regimens, FLT3 inhibitors, and consolidative stem cell transplantation for adult AML.
- Rare Haematology Cases: Management of hairy cell leukaemia, plasma cell leukaemia, and rare haematological malignancies requiring specialist expertise.
Advanced Procedures & Treatments
- Pediatric-Inspired ALL Protocols (CALGB 10403-style)
- Venetoclax-based AML Regimens
- FLT3 Inhibitor Therapy
- Minimal Residual Disease Monitoring
- Consolidative Stem Cell Transplantation
- Blinatumomab / Inotuzumab Therapy
- Ponatinib / BCR-ABL Inhibitors
- Hairy Cell Leukaemia Therapy (Cladribine, BRAF Inhibitors)
Professional Experience
Current Affiliation
- Consultant Haematologist, Adult Oncology Division — King Faisal Specialist Hospital & Research Centre (KFSHRC) Oncology Centre, Riyadh, Saudi Arabia (Present)
Past Affiliations
- Fellowship training in Adult Haematology and Acute Leukaemia — completed prior to consultancy at KFSHRC
Academic & Research Roles
- Contributing author — GCC Adult ALL Consensus Working Group
- Participant — KFSHRC Adult Leukaemia Multidisciplinary Team
- Investigator — multiple adult leukaemia clinical studies
Key Achievements
- Lead author on pediatric-inspired AYA T-ALL protocol study
- Lead author on 79-patient AYA ALL outcomes study
- Contributing author to GCC Adult ALL Consensus
- Published contributor to Blood (2023, 2024) on acute leukaemia outcomes
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- American Society of Hematology (ASH)
- European Hematology Association (EHA)
- Saudi Society of Haematology
- GCC Adult ALL Consensus Working Group
Research & Publications
Published Papers (Selected)
- Hanbali A, et al. Pediatric-Inspired Protocol for AYA T-Cell Acute Lymphoblastic Leukaemia. 2023. PubMed 36874377.
- Hanbali A, et al. Adolescent and Young Adult Acute Lymphoblastic Leukaemia — 79-Patient Analysis. 2021. PMC8488255.
- Hanbali A, et al. GCC Adult ALL Consensus Guidelines. Cancer Reports. 2024.
- Hanbali A, et al. Hairy Cell Leukaemia and Plasma Cell Leukaemia — Case Report.
- Hanbali A, et al. Acute Leukaemia Outcomes. Blood. 2023, 2024 (contributing author).
Ongoing Research & Clinical Interests
- Pediatric-inspired protocols in AYA acute leukaemia
- Minimal residual disease in adult ALL
- Rare haematological malignancies
- Regional consensus guidelines for adult leukaemia
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Haematology Consultation | ₹1,000 – ₹2,500 | $12 – $30 |
| Bone Marrow Biopsy & Aspirate | ₹8,000 – ₹25,000 | $100 – $300 |
| Chemotherapy (per cycle) | ₹40,000 – ₹2,00,000 | $480 – $2,400 |
| Autologous Stem Cell Transplant | ₹12,00,000 – ₹18,00,000 | $14,500 – $21,700 |
| Allogeneic Stem Cell Transplant | ₹18,00,000 – ₹30,00,000 | $21,700 – $36,100 |
| CAR-T Cell Therapy | ₹1,50,00,000 – ₹4,00,00,000 | $180,000 – $480,000 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Amr Hanbali use in Adult Haematology — Acute Leukaemia treatment?
Dr. Amr Hanbali uses advanced acute leukaemia technologies including pediatric-inspired AYA protocols (CALGB 10403-style), venetoclax-based AML regimens, FLT3 inhibitors, blinatumomab and inotuzumab immunotherapy for ALL, ponatinib for Ph+ leukaemia, minimal residual disease (MRD) monitoring, and consolidative stem cell transplantation referral pathways. Virtual consultations and remote second opinions are also available to international patients through Cancer Rounds.
2. What conditions does Dr. Amr Hanbali specialize in treating?
Dr. Amr Hanbali specialises in Acute Leukaemia and AYA Haematology, treating acute lymphoblastic leukaemia (B-ALL, T-ALL), acute myeloid leukaemia (AML), adolescent and young adult (AYA) leukaemia, chronic myeloid leukaemia (CML), myelodysplastic syndrome (MDS), hairy cell leukaemia, plasma cell leukaemia, and rare haematological malignancies. International patients seeking the best acute leukaemia doctor in India or Saudi Arabia benefit from his AYA expertise.
3. How do I book an appointment with Dr. Amr Hanbali?
Appointments with Dr. Amr Hanbali can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Amr Hanbali?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Amr Hanbali, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Amr Hanbali offer second opinions for Adult Haematology — Acute Leukaemia cases?
Yes. Second opinion consultations for Acute Leukaemia cases can be arranged via Cancer Rounds, enabling international patients — particularly AYA patients — to review pediatric-inspired protocol eligibility, MRD status, and transplant planning with Dr. Amr Hanbali.
